BMJ Mental Health
Cognitive signs and symptoms in people with a psychiatric diagnosis on semaglutide: a retrospective cohort study of 13 007 patients in the USA
Cohort study of 13,007 peopleInterventions
12 months, multicentre, declared ties to: National Institute for Health Research, KKT Technologies and Holmusk
- Semaglutide
- GLP-1 and incretin signalling
- Bipolar disorder
- Major depressive disorder
- Mental disorders
- Humans
The paper
University of Salento; Oxford Health NHS Foundation Trust
BMJ Mental Health, 20 Aug 2026
